Analystreport

BioXcel Therapeutics, Inc. (NASDAQ: BTAI) had its price target lowered by analysts at Truist Financial Co. from $125.00 to $71.00.

BioXcel Therapeutics, Inc.  (BTAI) 
Last bioxcel therapeutics, inc. earnings: 11/14 07:00 am Check Earnings Report